CD1d restricted natural killer T cells are not required for allergic skin inflammation

Journal of Allergy and Clinical Immunology

Volumn 118, Issue 6, 2006, Pages 1363-1368

  Elkhal, Abdallah ^a   Pichavant, Muriel ^a   He, Rui ^a   Scott, Jordan ^a   Meyer, Everett ^a   Goya, Sho ^a   Geha, Raif S ^a   Umetsu, Dale T ^a  

^a Children's Hospital   (United States)

Author keywords

allergic skin inflammation; Atopic dermatitis; eosinophils; NKT cells; T H2 cytokines

Indexed keywords

INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; MESSENGER RNA; METHACHOLINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; CYTOKINE RELEASE; FLUORESCENCE ACTIVATED CELL SORTER; LAVAGE; LUNG LAVAGE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN INFILTRATE; SKIN INFLAMMATION; SKIN SENSITIZATION; WILD TYPE;

ALLERGENS; ANIMALS; ANTIGENS, CD1; CD4-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; EOSINOPHILS; FEMALE; HYPERSENSITIVITY, IMMEDIATE; INTERLEUKINS; KILLER CELLS, NATURAL; LUNG; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; OVALBUMIN; SKIN;

EID: 33845207794     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2006.08.010     Document Type: Article

References (37)

1. Leung D.Y., and Bieber T. Atopic dermatitis. Lancet 361 (2003) 151-160
2. Wills-Karp M. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu Rev Immunol 17 (1999) 255-281
3. Wills-Karp M. Interleukin-13 in asthma pathogenesis. Immunol Rev 202 (2004) 175-190
4. Kaminishi K., Soma Y., Kawa Y., and Mizoguchi M. Flow cytometric analysis of IL-4, IL-13 and IFN-gamma expression in peripheral blood mononuclear cells and detection of circulating IL-13 in patients with atopic dermatitis provide evidence for the involvement of type 2 cytokines in the disease. J Dermatol Sci 29 (2002) 19-25
5. Johansson S.G., Hourihane J.O., Bousquet J., Bruijnzeel-Koomen C., Dreborg S., Haahtela T., et al., EAACI (the European Academy of Allergology and Cinical Immunology) Nomenclature Task Force. A revised nomenclature for allergy: an EAACI position statement from the EAACI Nomenclature Task Force. Allergy 56 (2001) 813-824
6. Godfrey D.I., Hammond K.J., Poulton L.D., Smyth M.J., and Baxter A.G. NKT cells: facts, functions and fallacies. Immunol Today 21 (2000) 573-583
7. Matsuda J.L., Naidenko O.V., Gapin L., Nakayama T., Taniguchi M., Wang C.R., et al. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J Exp Med 192 (2000) 741-754
8. Berzins S.P., Uldrich A.P., Pellicci D.G., McNab F., Hayakawa Y., Smyth M.J., et al. Parallels and distinctions between T and NKT cell development in the thymus. Immunol Cell Biol 82 (2004) 269-275
9. Kawano T., Cui J., Koezuka Y., Toura I., Kaneko Y., Motoki K., et al. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 278 (1997) 1626-1629
10. Spada F.M., Koezuka Y., and Porcelli S.A. CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells. J Exp Med 188 (1998) 1529-1534
11. Crowe N.Y., Uldrich A.P., Kyparissoudis K., Hammond K.J., Hayakawa Y., Sidobre S., et al. Glycolipid antigen drives rapid expansion and sustained cytokine production by NKT cells. J Immunol 171 (2003) 4020-4027
12. Kawano T., Cui J., Koezuka Y., Toura I., Kaneko Y., Sato H., et al. Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells. Proc Natl Acad Sci U S A 95 (1998) 5690-5693
13. Zhou D., Mattner J., Cantu III C., Schrantz N., Yin N., Gao Y., et al. Lysosomal glycosphingolipid recognition by NKT cells. Science 306 (2004) 1786-1789
14. Mattner J., Debord K.L., Ismail N., Goff R.D., Cantu III C., Zhou D., et al. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434 (2005) 525-529
15. Yoshimoto T., and Paul W.E. CD4pos, NK1.1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J Exp Med 179 (1994) 1285-1295
16. Carnaud C., Lee D., Donnars O., Park S.H., Beavis A., Koezuka Y., et al. Cutting edge: cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J Immunol 163 (1999) 4647-4650
17. Cui J., Watanabe N., Kawano T., Yamashita M., Kamata T., Shimizu C., et al. Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated Valpha14 natural killer T cells. J Exp Med 190 (1999) 783-792
18. Akbari O., Stock P., DeKruyff R.H., and Umetsu D.T. Role of regulatory T cells in allergy and asthma. Curr Opin Immunol 15 (2003) 627-633
19. Akbari O., Stock P., Meyer E., Kronenberg M., Sidobre S., Nakayama T., et al. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat Med 9 (2003) 582-588
20. Lisbonne M., Diem S., de Castro Keller A., Lefort J., Araujo L.M., Hachem P., et al. Cutting edge: invariant V alpha 14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model. J Immunol 171 (2003) 1637-1641
21. Spergel J.M., Mizoguchi E., Brewer J.P., Martin T.R., Bhan A.K., and Geha R.S. Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J Clin Invest 101 (1998) 1614-1622
22. Spergel J.M., Mizoguchi E., Oettgen H., Bhan A.K., and Geha R.S. Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis. J Clin Invest 103 (1999) 1103-1111
23. Ma W., Bryce P.J., Humbles A.A., Laouini D., Yalcindag A., Alenius H., et al. CCR3 is essential for skin eosinophilia and airway hyperresponsiveness in a murine model of allergic skin inflammation. J Clin Invest 109 (2002) 621-628
24. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29 (2001) e45
25. Clark R.A., Yamanaka K., Bai M., Dowgiert R., and Kupper T.S. Human skin cells support thymus-independent T cell development. J Clin Invest 115 (2005) 3239-3249
26. Clark RA, Chong B, Mirchandani N, Yamanaka KI, Murphy GF, Dowgiert RK, et al. A novel method for the isolation of skin resident T cells from normal and diseased human skin. J Invest Dermatol 2006;126:1059-70.
27. Stevens T.L., Bossie A., Sanders V.M., Fernandez-Botran R., Coffman R.L., Mosmann T.R., et al. Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells. Nature 334 (1988) 255-258
28. Smiley S.T., Kaplan M.H., and Grusby M.J. Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells. Science 275 (1997) 977-979
29. Korsgren M., Persson C.G., Sundler F., Bjerke T., Hansson T., Chambers B.J., et al. Natural killer cells determine development of allergen-induced eosinophilic airway inflammation in mice. J Exp Med 189 (1999) 553-562
30. Chen Y.H., Chiu N.M., Mandal M., Wang N., and Wang C.R. Impaired NK1+ T cell development and early IL-4 production in CD1-deficient mice. Immunity 6 (1997) 459-467
31. Behar S.M., Dascher C.C., Grusby M.J., Wang C.R., and Brenner M.B. Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis. J Exp Med 189 (1999) 1973-1980
32. Wills-Karp M., Luyimbazi J., Xu X., Schofield B., Neben T.Y., Karp C.L., et al. Interleukin-13: central mediator of allergic asthma. Science 282 (1998) 2258-2261
33. Grunig G., Warnock M., Wakil A.E., Venkayya R., Brombacher F., Rennick D.M., et al. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 282 (1998) 2261-2263
34. Walter D.M., McIntire J.J., Berry G., McKenzie A.N., Donaldson D.D., DeKruyff R.H., et al. Critical role for IL-13 in the development of allergen-induced airway hyperreactivity. J Immunol 167 (2001) 4668-4675
35. Webb D.C., Matthaei K.I., Cai Y., McKenzie A.N., and Foster P.S. Polymorphisms in IL-4R alpha correlate with airways hyperreactivity, eosinophilia, and Ym protein expression in allergic IL-13-/- mice. J Immunol 172 (2004) 1092-1098
36. Bagley C.J., Lopez A.F., and Vadas M.A. New frontiers for IL-5. J Allergy Clin Immunol 99 (1997) 725-728
37. Rothenberg ME. Eosinophilia. N Engl J Med 1998;338:1592-600.